Aug 2026· Nature Communications· Vol 17· 0 citations
Medicine
TL;DR
It is shown that a transient Numb-enriched state emerges during early postnatal development, expands during the second postnatal week and subsequently declines and is disrupted by neonatal inflammation.
Abstract
Early-life microglia are diverse and support brain development beyond immune surveillance, but the transient states associated with postnatal maturation remain poorly understood. Here we show, using a time-resolved single-cell atlas of neonatal mouse brain immune cells, that a postnatal Numb-enriched microglial state emerges during early postnatal development, expands during the second postnatal week and subsequently declines. This state is characterized by neurodevelopment-related gene expression programs and distinct metabolic features. Trajectory inference, cross-atlas mapping and RNAscope validation support its temporal pattern. During the period when this state expands, microglial depletion preserves gross myelination but alters synaptic protein composition and disrupts dendritic and cortical layer maturation, particularly in the primary somatosensory cortex. Neonatal lipopolysaccharide challenge impairs the establishment of the Numb-enriched state and induces an early glycolytic response followed by recovery-phase inflammatory states. These findings identify a developmentally timed microglial state associated with cortical maturation and vulnerable to neonatal inflammation in mice. Microglia help shape the developing brain, but how their early-life states change over time remains unclear. Here, the authors show that a transient Numb-enriched state marks postnatal cortical maturation in mice and is disrupted by neonatal inflammation.
This review synthesizes current understanding of how developmental programming, regional specialization, temporal regulation, and metabolic adaptation collectively shape dynamic microglial states across health and disease and discusses emerging therapeutic strategies aimed at context-dependent modulation of microglial...
Shun-Qi Wang, Yao Wang, Chun-Yang Hou et al.· Cellular and molecular neuro...· 0 citations
Aging is associated with immune dysregulation in the brain and is the greatest risk factor for many neurodegenerative diseases. Rejuvenation interventions can mediate beneficial effects. Microglia are major contributors to neurodegenerative disease progression; however, the molecular changes underlying brain aging and...
H. Naz, Nannan Lu, Caroline C. Escoubas et al.· Cell Reports· 0 citations
Brain aging is a major risk factor for cerebrovascular and neurodegenerative diseases, yet continuous cell-type changes across the human lifespan remain incompletely defined. Here, we integrate 15 prefrontal cortex (PFC) snRNA-seq datasets from 158 neurologically healthy donors (19–101 years) to construct an atlas of...
Rui-Ze Niu, Meng-Yuan Zhang, Zhi-Lan Yang et al.· npj Aging· 0 citations
It is suggested that microglial SIRPα acts as a checkpoint molecule that restrains aging-associated glial activation in white matter, and that the resulting activation of microglia and astrocytes is not accompanied by overt MBP-defined myelin loss or accelerated motor decline.
Etsumi Oike, Mizuki Ueda, Shunya Hanzawa et al.· Journal of Neuroinflammation· 0 citations
Microglia are central regulators of synaptic structure and cognitive function, yet under chronic inflammatory conditions, they can adopt stress-associated states associated with neuronal and synaptic vulnerability. Although inflammation-driven cognitive decline is often attributed to synapse loss, increasing evidence...
G. Ayyubova, E. Gasimov, F. Rzayev et al.· Scientific Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.